Originally published by The Medicine Maker

By Maryam Mahdi

Boston Scientific and IBM Research are collaborating to create an AI-based platform that provides doctors with personalized insights into patients’ experiences with chronic pain – measuring and analyzing those experiences in a way that would not be possible without AI. By collating data from spinal cord stimulation therapy studies, the team are developing an approach that will “objectively and continuously measure chronic pain” in a bid to move medical assessment and treatment beyond arbitrary descriptors of pain level or strength.

We caught up with Rafael Carbunaru, Vice President of Research and Development, Neuromodulation, Boston Scientific, and Jeff Rogers, Global Research Leader for Digital Health at IBM Research, to talk about the platform and the role AI will play in the future treatment landscape for chronic pain.

Continue reading here

Boston Scientific

Boston Scientific

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.

More from Boston Scientific